Bahamas vs New Caledonia: The number of people with susceptibility test result for rifampicin
Bahamas
12
in 2021
New Caledonia
15
in 2021
Bahamas rank
138th
New Caledonia rank
135th
The number of people with susceptibility test result for rifampicin over time
- Bahamas
- New Caledonia
How they compare
New Caledonia currently reports 15 against 12 in Bahamas, a difference of 3.
That makes New Caledonia's figure about 1.2 times Bahamas's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was New Caledonia ahead.
Bahamas ranks 138th and New Caledonia ranks 135th of 155 countries.
New Caledonia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bahamas | New Caledonia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 17.67 | 21.33 | 3.67 | New Caledonia |
| 2020s | 16 | 19.5 | 3.5 | New Caledonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Bahamas or New Caledonia?
- New Caledonia, at 15 against 12 in Bahamas as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Bahamas and New Caledonia?
- 3, with New Caledonia ahead.
- How many years of comparable data are there for Bahamas and New Caledonia?
- 5 years are reported by both, from 2017 to 2021.
- How do Bahamas and New Caledonia rank globally for the number of people with susceptibility test result for rifampicin?
- Bahamas ranks 138th and New Caledonia ranks 135th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.